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Background: Adult neurogenesis in the subgranular zone of the hippocampus is involved in learning, memory,
and mood control. Decreased hippocampal neurogenesis elicits significant behavioral changes, including cognitive
impairment and depression. Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions of the
intestinal tract, and cognitive dysfunction and depression frequently occur in patients suffering from this disorder.
We therefore tested the effects of chronic intestinal inflammation on hippocampal neurogenesis.
Methods: The dextran sodium sulfate (DSS) mouse model of IBD was used. Mice were treated with multiple-cycle
administration of 3% wt/vol DSS in drinking water on days 1 to 5, 8 to 12, 15 to 19, and 22 to 26. Mice were sacrificed
on day 7 (acute phase of inflammation) or day 29 (chronic phase of inflammation) after the beginning of the treatment.
Results: During the acute phase of inflammation, we found increased plasma levels of IL-6 and TNF-α and increased
expression of Iba1, a marker of activated microglia, accompanied by induced IL-6 and IL-1β, and the cyclin-dependent
kinase inhibitor p21Cip1 (p21) in hippocampus. During the chronic phase of inflammation, plasma levels of IL-6
were elevated. In the hippocampus, p21 protein levels were continued to be induced. Furthermore, markers of
stem/early progenitor cells, including nestin and brain lipid binding protein (BLBP), and neuronal marker doublecortin
(DCX) were all down-regulated, whereas glial fibrillary acidic protein (GFAP), a marker for astroglia, was induced. In
addition, the number of proliferating precursors of neuronal lineage assessed by double Ki67 and DCX staining was
significantly diminished in the hippocampus of DSS-treated animals, indicating decreased production of new neurons.
Conclusions: We show for the first time that chronic intestinal inflammation alters hippocampal neurogenesis. As p21
arrests early neuronal progenitor proliferation, it is likely that p21 induction during acute phase of inflammation
resulted in the reduction of hippocampal neurogenesis observed later, on day 29, after the beginning of DSS
treatment. The reduction in hippocampal neurogenesis might underlie the behavioral manifestations that occur in
patients with IBD.
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In the adult brain, neurogenesis occurs in the subventri-
cular zone and the subgranular zone (SGZ) of the den-
tate gyrus (DG) of the hippocampus [1-3]. In humans,
new neurons are generated in the hippocampus through-
out adulthood [4]. It is well established that neurogen-
esis is required for many forms of cognitive function
involving the hippocampus [5-11]. Low proliferation and* Correspondence: chesnokovav@cshs.org
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correlate with memory dysfunction in humans [12], and
in other species, direct or indirect stimulation of neuro-
genesis can enhance cognitive function [8,13]. Chronic
stress decreases hippocampal neurogenesis and results
in hippocampal atrophy and depression-like behavior
[14,15], and disruption of neurogenesis produces stress-
induced depression-like behaviors in mice [10].
During acute or chronic inflammation, circulating
pro-inflammatory cytokines can trigger significant and
long-lasting behavioral changes, including the develop-
ment of cognitive impairment and depression [16-19].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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esis in the SGZ [20-22]. Therefore, cytokine-induced
disruption of neurogenesis might be a key link between
chronic inflammation and cognitive impairment and
depression.
The cyclin-dependent kinase (Cdk) inhibitor p21Cip1
(p21) restrains cell cycle progression and arrests the cell in
the G1 phase [23]. Previously, we reported that p21 is in-
duced in early neuronal progenitors and immature neurons
in the SGZ, and limits cell proliferation, effectively sup-
pressing neurogenesis [24-26]. Furthermore, acute systemic
inflammation and pro-inflammatory cytokines increase
SGZ p21 expression, which, in turn, restrains proliferation
of hippocampal precursors of neuronal lineage [25].
Unlike acute inflammation, inflammatory bowel dis-
ease (IBD) which comprises Crohn’s disease and ulcera-
tive colitis is a chronic condition with a relapsing course
and is thought to arise as a result of genetic susceptibil-
ity, abnormal intestinal permeability, and abnormal in-
nate and adaptive immune responses to the intestinal
microbiota [27,28]. IBD affects about 1.4 million people
in the USA and 2.2 million people in Europe. Recent
studies demonstrated the connection between intestinal
inflammation and changes in brain function. Inflamma-
tion in the bowel is associated with a more excitable
CNS, as revealed by an increase in seizure susceptibility
that correlates with the severity of inflammation. Elec-
trophysiological recordings of hippocampal slices from
animals with intestinal inflammation show increased ex-
citability, likely due to increased TNF-α signaling and
microglial activation within the brain [29]. Others have
demonstrated that chronic experimental colitis increases
anxiety behavior in mice [30]. It is likely that peripheral in-
flammation could account for at least some of the neuro-
logical and behavioral symptoms associated with chronic
inflammatory diseases. Indeed, IBD patients have higher
rates of panic disorder and obsessive-compulsive disorder
[31-33] and a twofold increase in the rates of anxiety and
depression [31-34]. In addition, people with IBD show
cognitive impairment [35-37]. Mechanisms underlying a
link between chronic intestinal inflammation and behavior
changes are largely unknown.
One well-characterized mouse model of IBD involves
repeated administration of dextran sodium sulfate (DSS)
in drinking water [38]. DSS is a large molecule (molecu-
lar weight (MW) 30,000 to 50,000) that does not cross
the blood-brain barrier. Epithelial cell toxicity, increased
intestinal permeability, and macrophage activation have
been implicated in the deleterious effects of DSS. The
DSS model is characterized by colonic epithelial cell
lesions and acute (7 to 14 days after the beginning of the
treatment) and later chronic intestinal inflammation with
neutrophils and macrophages present within damaged
segments [39]. After stopping DSS administration, thecolon regenerates slowly over several weeks. Typically,
mice lose approximately 10% to 15% of body weight dur-
ing the first two cycles of DSS treatment, but the weight is
gradually restored by day 28.
The purpose of this study was to use this mouse model
of IBD to examine the effects of chronic peripheral inflam-
mation on new neuron proliferation and development in
the hippocampus. We show here that inflammation in-
creases pro-inflammatory cytokine expression in the per-
iphery and in the hippocampus, which, in turn, activates
SGZ p21. p21 restrains neuronal progenitor proliferation,
and decreased levels of doublecortin (DCX) were observed
in DSS-treated mice, indicating reduced hippocampal
neurogenesis, whereas glial fibrillary acidic protein (GFAP),
a marker of astroglia, was induced. Thus, chronic periph-
eral inflammation provokes changes in hippocampal neuro-
genesis that might underlie behavior sequelae of IBD or
other chronic peripheral inflammatory diseases.Methods
Experimental animals and chronic intestinal inflammation
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Institutional Animal
Care and Use Committee at Cedars-Sinai Medical Cen-
ter. Two-month-old C57Bl/6 female mice were used for
the experiments. We employed females only because
males are more sensitive to the disruptive effects of DSS
on colon epithelia and can develop severe inflammation
and die. Inflammation was induced using multiple-cycle
administration of 3% wt/vol DSS (MP Biomedicals, Santa
Ana, CA, USA) in drinking water on days 1 to 5, 8 to
12, 15 to 19, and 22 to 26 as previously described [38].
Mice were sacrificed on day 29 after the beginning of
DSS administration. Three independent experiments were
carried out (six mice/group in each experiment). Both left
and right hippocampi from three mice per treatment
group were isolated for protein analysis and from another
three mice per treatment group for RNA isolation. All
samples were run individually. Trunk blood was collected,
and circulating cytokines were measured in serum using
ELISA (eBioscience, San Diego, CA, USA).
Additional groups of DSS-treated and control mice (five
mice/group) were anesthetized and perfused with parafor-
maldehyde (4% in 0.1 M phosphate buffer, pH 7.4) for im-
munohistochemistry studies.
In a separate experiment, five mice that underwent
one cycle of DSS water (days 1 to 5) were sacrificed
7 days after the beginning of DSS treatment; hippo-
campi from three mice from each group were col-
lected for protein analysis and from two mice per
group for RNA isolation. Trunk blood was also collected
Zonis et al. Journal of Neuroinflammation  (2015) 12:65 Page 3 of 12for cytokine measurements. This experiment was carried
out twice.
Evaluation of intestinal inflammation
Colon and cecum were harvested from all experimental
mice and scored for the presence and severity of colitis.
Histology was used to evaluate inflammation, extent, re-
generation, crypt damage, and percentage involvement.
The histologic scoring for colitis is based on an established
scale using inflammatory and epithelial parameters, as pre-
viously reported [38,40,41], and was performed by an expe-
rienced pathologist who was blind to the experimental
treatment. Disease severity was determined in colon and
cecum using a combination of microscopic (grade 0, nor-
mal; grade 1, mild; grade 2, moderate; grade 3, severe) and
histological (grade 0, histological score 0 to 1; grade 1, 2 to
4; grade 2, 5 to 7; grade 3, 8 to 10; grade 4, 11 to 14) scores.
Quantitative real time PCR
Total RNA was isolated from hippocampi with TRIzol
reagent (Thermo Fisher Scientific, Waltham, MA, USA).
After DNAse I treatment (TURBO DNA free, Ambion,
Austin, TX, USA), cDNA was synthesized from 3 μg of
purified RNA by the SuperScript II First-Strand cDNA
synthesis system (Thermo Fisher, Waltham, MA, USA)
according to manufacturer’s instructions. Quantitative
PCR was performed in a 20-μl reaction using IQ SYBR
Green Master Mix in a Bio-Rad IQ5 instrument (Bio-
Rad Laboratories, Hercules, CA, USA). Specific validated
primers for murine IL-1β, IL-6, TNF-α, and p21 were
purchased from SuperArray (Qiagen, Germantown, MD,
USA). Triplicate PCR reactions yielded a threshold cycle
(Ct) average, with coefficient of variance of <0.05%, and
were used to determine ΔCt values [ΔCt = Ct of the tar-
get gene minus Ct of the housekeeping GAPDH gene].
A comparative threshold cycle (CT) method was used
for relative gene expression quantification. All experiments
included template-free (water) and reverse transcriptase-
minus controls to ensure no contamination. Relative quan-
tities of mRNAs in experimental samples were determined,
normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), and expressed in arbitrary units as the fold dif-
ference from control (control was taken as one).
Adult neuronal progenitor cell cultures
Cultures were prepared and conducted according to
published protocols [3,42]. Two-month-old C57Bl/6
male mice were sacrificed and the hippocampi dis-
sected and dissociated using Papain Dissociation Sys-
tem (Worthington Biochemicals, Lakewood, NJ, USA).
Hippocampal neuronal progenitor cells (NPC) were
isolated and cultured using Neural Stem Cell Expan-
sion Kit Neurosphere System in serum-free neurobasal
A-medium (R&D Systems, Minneapolis, MN, USA) asdescribed [26]. The single-cell suspension was re-
suspended in DMEMF-12 medium supplemented with N-
2 Plus Media Supplement, 2 mM L-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 10 ng/ml FGF-2, and
20 ng/ml EGF for 7 days; then, the spheres were collected
and dispersed to individual cells, plated on polyornithine-
covered culture dishes, and after three passages differenti-
ation was induced by growing in Complete NeuroCult
NSC Differentiation Medium (StemCell Technologies,
Vancouver, British Columbia, Canada) in the absence of
FGF-2 and EGF. Under these conditions, NPC lose nestin
and sex-determining region Y-box 2 (SOX2) and primarily
generate neuroblasts and astroglia [43-45]. Plated on ECL
cell attachment matrix coated coverslips (Upstate Biotech-
nology (Lake Placid, NY, USA), 5 to 10 μg/cm2) in 24 well
plates were 5 × 104 cells/ml, and they were cultured for
8 days in differentiating conditions in the presence of mur-
ine cytokines, 10 ng/ml IL-1β or 50 ng/ml IL-6 or 20 ng/ml
TNF-α (all from Biolegend, San Diego, CA, USA), with half
the medium changed and fresh cytokine added every other
day. A portion of the cells was collected for Western blot,
and the other portion was fixed in 4% paraformaldehyde
and immunocytochemistry performed to detect neuronal
markers.
Protein isolation and Western blot analysis
Protein was isolated using an immunoprecipitation kit
(Roche Diagnostics, Indianapolis, IN, USA) and Western
blot analysis was performed as described [25]. Twenty-
five micrograms of protein lysate was resolved by SDS-
PAGE and electroblotted onto PVDF membrane (EMD
Millipore, Billerica, MA, USA). The membrane was
blocked by 5% nonfat dry milk in TBST (50 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 0.05% Tween 20) and incu-
bated overnight with primary antibodies at 4°C, followed
by incubation with corresponding secondary antibodies
(Sigma-Aldrich, St. Louis, MO, USA) for 2 h at room
temperature. Immunoreactive bands were detected using
Bio-Rad Molecular Imager® ChemiDoc™ XRS And Image
Lab™ Software (BioRad Laboratories, Hercules, CA, USA).
The following antibodies were used: nestin (1:1,000), brain
lipid binding protein (BLBP, 1:800), ionized calcium-
binding adapter molecule-1 (Iba1, 1:1,000), and Ki-67
(1:1,000), all from Abcam (Cambridge, MA, USA); p21
(1:300, Cell Signaling Technology, Danvers, MA, USA),
DCX (1:1,000), and GAPDH (1:200), all from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); and glial GFAP
(1:1,000, EMD Millipore, Billerica, MA, USA).
Immunocytochemistry and immunohistochemistry
Fixed cells or Paraffin brain sagittal sections on coverslips
were double-labeled with primary antibodies conjugated
with Alexa 488 or Alexa 568 fluorescent dyes (1:400,
Thermo Fisher, Waltham, MA, USA). The following
Zonis et al. Journal of Neuroinflammation  (2015) 12:65 Page 4 of 12primary antibodies were used: p21 (1:50, BD Biosciences,
San Jose, CA, USA), SOX2 (1:100 or 1:30), and GFAP
(1:50) (both EMD Millipore, Billerica, MA, USA); DCX
(1:20) and Ki-67 (1:1,000), all from Abcam (Cambridge,
MA, USA). DNA (nuclei) was stained with DAPI (Prolong
Gold, Thermo Fisher, Waltham, MA, USA). Antigen re-
trieval was performed in 10 mM sodium citrate.
In vitro, immunoreactive cells were determined by im-
munocytochemistry and counted in five to ten random
fields (total number of cells between 1,000 and 5,000 for
each antibody).
In vivo, five animals/group were analyzed. Ki-67 and
DCX staining were analyzed on 5-μm sagittal sections of
the left half of the brain from 0.36 to 0.6 mm lateral to
the midline [46]. Positive cells in every third section (a
total of 30 sections) from each mouse were counted
under × 100 objective, and the sum was multiplied by 3
to estimate the total number of Ki-67- or DCX-positive
cells in the region. SOX2, p21, and DCX staining were ana-
lyzed on 5-μm sagittal sections of the left half of the brain
from 0.46 to 0.6 mm lateral to the midline. Six slides were
analyzed for each animal. Some sections were double-
labeled to detect DCX and Ki-67, p21 and SOX2, or p21
and DCX co-localization. Cells were counted if they were
in or touching the SGZ and were excluded if they were
more than two cell diameters away from the SGZ [47].
Samples were imaged with a Leica TCS/SP spectral con-
focal scanner (Leica Microsystems, Mannheim, Germany)
in dual emission mode to distinguish autofluorescence from
specific staining.
Statistical analysis
Nonparametric Wilcoxon rank sum test was used to test
the differences in protein and mRNA levels across the
groups. The average numbers of cells positive for Ki-67,
DCX, or for both (Ki-67+DCX+) were compared usingFigure 1 Chronic intestinal inflammation in mice on day 29 after the be
in the course of dextran sodium sulfate (DSS) treatment from three independ
and DSS-treated mice (n = 8). (C) Immunohistochemical analysis of intestinal i
Arrow points to the site of severe transmural inflammation with loss of entire
Arrow points to severe submucosal inflammation with loss of crypts while themultivariate analysis of variance (MANOVA) followed
by the post hoc Tukey test. The average numbers of cells
per slide positive for SOX2, p21, DCX, or doubly posi-
tive (p21+ SOX2+ and p21+ DCX+) were compared using
the Student t-test with Satterthwaite correction.
Results
Chronic intestinal inflammation in DSS-treated mice
To induce intestinal inflammation, mice received four
cycles of DSS or normal drinking water (controls) for
26 days. Body weight was monitored twice a week. Loss
of 7% to 15% body weight initially was observed in DSS-
treated animals, and normal weight was restored by day
26 (Figure 1A). The mice were sacrificed on day 29 after
the beginning of DSS administration. Trunk blood was
collected, and serum levels of TNF-α and IL-6 were mea-
sured. TNF-α was below detection in both experimental
and control groups of animals. IL-6 was below the level of
detection (<2.5 pg/ml) in control mice, whereas it was
present in the serum of DSS-treated animals indicating
the presence of systemic inflammation (Figure 1B). Signs
of intestinal inflammation were assessed histologically by a
trained pathologist to evaluate the extent, regeneration,
crypt damage, and percentage involvement in cecum and
colon as described [38,41,48]. All animals exhibited signs
of intestinal inflammation as evidenced by infiltration of
inflammatory cells and loss of crypts (microscopic scores
1 to 2, average histological scores 10.2 ± 1.7, n = 15) on
day 29 (Figure 1C).
Chronic intestinal inflammation reduces hippocampal
neurogenesis
At the conclusion of the experiment on day 29, RNA
and protein were isolated from the whole hippocampi.
We analyzed mRNA levels of pro-inflammatory cyto-
kines, as well as neuronal markers in the hippocampi ofginning of DSS treatment. (A) Cumulative change of body weight (BW)
ent experiments; n = 15 mice analyzed. (B) Serum IL-6 levels in control
nflammation (H&E). Inflammation sites are marked by dotted lines. Cecum:
crypts and endothelium and infiltration of inflammatory cells. Colon:
surface epithelium is still intact and to infiltration of inflammatory cells.
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markers showed decreased levels of nestin and BLBP,
both markers of stem/early progenitor cells, whereas
levels of GFAP were up-regulated in DSS-treated mice,Figure 2 Chronic intestinal inflammation negatively affects hippocam
of DSS treatment. (A) Western blot analysis of markers of neurogenesis and p
blots are shown depicting pooled samples derived from DSS-treated and con
individual samples run together, normalized to GAPDH and presented a
proinflammatory cytokines, markers of neurogenesis, and p21 in the hip
three independent experiments. All samples from three experiments (n
Results are expressed in fold change vs. control taken as 1 (broken line);
DCX, doublecortin; DSS, dextran sodium sulfate; GAPDH, glyceraldehydeindicative of activated astroglia. p21 was also induced
compared to the controls, and DCX protein levels were
decreased, indicating that neurogenesis was reduced in
DSS-treated mice (Figure 2A,B). Real-time PCR resultspal neurogenesis. Mice were sacrificed on day 29 after the beginning
21. Three independent experiments were performed, and representative
trol mice; (B) intensities of protein bands were quantified from nine
s a fold change relative to control animals; (C) mRNA levels of
pocampus of DSS-treated mice. Data are shown as mean ± SEM of
= 9) were run together in triplicates and normalized against GAPDH.
*p < 0.05, **p < 0.01. BLBP, brain lipid binding protein; Cont, control;
3-phosphate dehydrogenase; GFAP, glial fibrillary acidic protein.
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creased more than twofold accompanied by a fourfold
increase in p21 mRNA levels, whereas nestin, a marker
of stem/early progenitor cells, and DCX, a marker of
newly developing neurons, were both down-regulated.
At the same time, GFAP mRNA expression was induced
(Figure 2C).Figure 3 Acute intestinal inflammation activates hippocampal microg
treatment. (A) Plasma levels of pro-inflammatory cytokines (n = 6/group); (B
(n = 3/group). Experiment was repeated two times, and representative blot
Data are shown as mean ± SEM of two independent experiments. Samples
and normalized against GAPDH. Results are expressed in fold change vs. co
dextran sodium sulfate; GAPDH, glyceraldehyde 3-phosphate dehydrogenaThe observed changes in neurogenesis could be a re-
sult of the action of cytokines released by activated
microglia. We therefore tested the expression of Iba1, a
marker of activated microglia. Iba1 was not induced in
the hippocampi of DSS-treated mice on day 29 at the
conclusion of experiment (data not shown). In a separate
experiment, we sacrificed a group of mice 7 days afterlia. Mice were sacrificed on day 7 after the beginning of DSS
) Western blot analysis of Iba1, IL-6, and p21 in the hippocampus
s are shown; (C) mRNA levels of pro-inflammatory cytokines and p21.
from two experiments (n = 4/group) were run together in triplicates
ntrol taken as 1 (broken line); *p < 0.05; **p < 0.01. Cont, control; DSS,
se.
Figure 4 Proinflammatory cytokines induce p21 and decrease
neurogenesis in NPC. (A)Western blot analysis of NPC differentiated in
the presence of 10 ng/ml IL-1β or 50 ng/ml IL-6 or 20 ng/ml TNF-α for
8 days. (B) The graph depicts the percentage of Tuj-1+ neuroblasts and
GFAP+ glia cells among NPC cells differentiated untreated (control) or in
the presence of 50 ng/ml IL-6. Data are presented as a mean ± SEM,
*p< 0.05. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GFAP,
glial fibrillary acidic protein; Tuj-1, neuron-specific class III beta-tubulin.
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the acute phase of inflammation. At this time point,
plasma levels of TNF-α were elevated. IL-6 was below
detection in control mice, whereas was significantly ele-
vated in DSS-treated animals, indicating the presence of
systemic inflammation (Figure 3A). These mice exhib-
ited increased Iba1 and IL-6 protein levels, in accord-
ance with induced IL-1β and TNF-α mRNA expression
in the hippocampus (Figure 3B,C). High-cytokine levels
might trigger p21 as shown previously [25,49]. Indeed,
markedly up-regulated p21 mRNA and protein levels
were also observed in the hippocampi of mice in the
acute phase of inflammation (Figure 3B,C).
Pro-inflammatory cytokines induce p21 and decrease
neurogenesis in NPC
To further examine mechanisms underlying DSS-induced
decrease in neurogenesis, we isolated hippocampal neur-
onal progenitor cells from naïve mice and allowed these
cells to differentiate in the presence of 10 ng/ml IL-1β or
50 ng/ml IL-6 or 20 ng/ml TNF-α for 8 days. Western blot
analysis shows that all three cytokines markedly increased
p21 expression in differentiating neuronal progenitors
(Figure 4A).We next tested the direct effect of one of the cytokines,
IL-6, on NPC differentiation. Cells were double-stained
for βIII-tubulin, a marker of committed neuroblasts that is
recognized by antibodies to Tuj-1, and for GFAP, and the
percent of cells expressing each antigen was calculated.
Exposure of NPC to IL-6 resulted in decreased number of
Tuj-1-positive cells (from 41% ± 6.4% in untreated cells to
22.39% ± 5.2% in IL-6-treated cells, p < 0.05), while the
number of GFAP-positive cells increased (from 5.41% ±
1.3% in untreated cells to 14.51% ± 5.3% in IL-6 treated
cells, p < 0.05) (Figure 4B).Chronic intestinal inflammation induces SGZ p21 and
suppresses neuronal lineage proliferation
We showed previously that p21 is exclusively expressed in
the SGZ of the hippocampus [24,26]. During the chronic
phase of inflammation, immunofluorescent staining and
confocal analysis of paraffin sections revealed increased
number of p21+ in the SGZ of DSS-treated mice. We also
observe increased number of p21+ cells in the hilus. Intense
p21 staining was observed in SOX2+ and in DCX+ cells
(Figure 5A). Light green p21+ cells negative for SOX2 or
DCX likely represent p21+nestin+ cells as was shown earlier
[26]. Average cell number positive for p21, SOX2, and
DCX, and doubly positive p21+/SOX2+ and p21+/DCX+,
was calculated, and an approximately tenfold increase in
p21+ cells, and an increased percentage of SOX+ (8.2% ±
1.9% vs. 28% ± 4.5%, p < 0.01) and DCX+ (6.1% ± 2.3% vs.
25% ± 5.9%, p < 0.05) cells expressing p21, was detected in
DSS-treated animals as compared to controls (Figure 5A,B,
C,D), in agreement with our Western blot data (Figure 2B,
C). Thus, DSS treatment resulted in the increased number
of neuronal progenitors expressing p21.
Ki-67 is a marker of cell proliferation. To further
assess the effects of chronic inflammation on the prolif-
eration of neuronal progenitors in the hippocampus,
paraffin sections were co-labeled with DCX and Ki-67
antibodies. A decreased number of DCX+, Ki-67+, and
DCX+/Ki-67+ co-labeled cells in the SGZ were observed
in the hippocampi of DSS-treated mice (Figure 6A,B),
confirming diminished neuronal lineage proliferation.
Thus, the decline of neuronal progenitor proliferation in
DSS-treated mice was associated with p21 induction in
the SGZ of hippocampus.Discussion
DSS-induced intestinal inflammation has two phases:
acute (days 5 to 14), with pro-inflammatory cytokine re-
lease and extensive weight loss, and chronic (days 20 to
28), when the cytokine profile changes to T-helper IL-
12/INF-γ secretion, and the weight loss partially or com-
pletely recovers [39]. This resembles the course of IBD
in humans, characterized by acute disease exacerbation
Figure 5 Chronic intestinal inflammation induces SGZ p21. (A) The confocal microscopic analysis shows that p21 (nuclear, green) is co-localized
with SOX2 (nuclear, pink) or DCX (cytoplasmic, red) and is more abundant in the SGZ of DSS-treated hippocampus. Five slides/group were analyzed and
representative images are shown; arrows indicate cell expressing p21 and co-localization of p21 with SOX2 or DCX. (B) Average number of SOX2+, p21+,
and SOX2+/p21+ cells/per slide. (C) Average number of DCX+, p21+, and DCX+/p21+ per slide. (D) Percent of p21+ cell in SOX2+ or DCX+ cells/ per slide in
the hippocampus of control and DSS-treated mice. Six slides/mouse/five mice were analyzed. Data are presented as a mean ± SEM. Statistical analysis was
performed with the Student t-test with Satterthwaite correction. *p< 0.05; **p< 0.01. Cont, control; DCX, doublecortin; DSS, dextran sodium sulfate; SOX2,
sex-determining region Y-box 2.
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assessed intestinal inflammation during the acute phase
of experiment. However, all experimental animals still
exhibited signs of intestinal inflammation on day 29. At
that time point, the pathological analysis indicated the
presence of inflammation in both the colon and cecum
concordant with the increased levels of circulating pro-
inflammatory cytokine IL-6 in DSS-treated mice.
Peripheral inflammation could affect hippocampal
neurogenesis by several mechanisms. Cytokines in the sys-
temic circulation can access the brain [50,51], or cytokines
produced in periphery can signal the brain through the
vagal nerve [52]. We as well as others have demonstratedthat systemic administration of lipopolysaccharides (LPS)
induced the expression of pro-inflammatory cytokines
in the brain [25,51,53-55]. Engagement of this immune
system-to-brain communication ultimately leads to the ac-
tivation of resident microglia. Activated microglia can either
diminish the production and survival of new neurons or
protect developing neurons from apoptosis depending on
the duration of inflammation, levels of activation, and the
secreted cytokine profile [56-59]. Microglia activation im-
pacts not only the production, but also the migration and
the recruitment of new neurons [60]. During the acute
phase of colitis, on day 7, DSS treatment stimulated resi-
dent hippocampal microglia, evidenced by increased Iba1
Figure 6 Chronic intestinal inflammation suppresses proliferation of neuronal lineage. (A) Numbers of DCX+, Ki-67+, and DCX+/Ki-67+ cells
in the SGZ of control and DSS-treated mice. For each sample, hippocampi from five mice/group were analyzed. Data are presented as a mean ±
SEM. Multivariate analysis of variance (MANOVA) showed significant group effect in the cell count positive for Ki-67+, DCX+, and Ki-67+/DCX+
F38 ¼ 4:33; p ¼ 0:0432
 
;  p≤0:05;   p < 0:01; (B) The confocal microscopic analysis of proliferating DCX+/Ki-67+ cells in the SGZ of control
and DSS-treated mice. DCX cytoplasmic, red; Ki-67 nuclear, green. DCX, doublecortin; DSS, dextran sodium sulfate.
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the factors being released [60,61]. Increased levels of pro-
inflammatory cytokines, as observed in hippocampi of
DSS-treated mice, can be detrimental to newly developing
neurons. Cytokines can be expressed not only by activated
microglia, but also by astroglia and neurons [62]. Regardless
of the cells of origin, local pro-inflammatory cytokines can
negatively affect hippocampal neurogenesis, as was demon-
strated for TNF-α, IL-6, and IL-1β [20-22,25,63]. In mice,
approximately 3 weeks are required for the new neurons to
mature [64,65]; therefore, the effects of activated microglia
on day 7 may manifest 3 weeks later. Indeed, neurogenesis
was markedly diminished in animals sacrificed on day 29
after DSS treatment.
Although the mechanism by which pro-inflammatory
cytokines reduce neurogenesis is not fully understood, we
believe that p21 might be a key mediator of this process.p21 can be stimulated directly by pro-inflammatory cyto-
kines [66-68], In addition, p21 can be stimulated by tran-
scription factor Notch1 expressed in neuronal stem cells
[69]. Notch1 is known to suppress cell proliferation by
stimulating p21 expression [70] and can induce p21 in
neuronal progenitors in response to cytokine activation,
suppressing neurogenesis and stimulating generation of
astrocytes [71]. Although Iba1 protein levels were not in-
creased in the chronic phase of intestinal inflammation,
we still observed up-regulation of p21 and GFAP, a marker
for astroglia. It is likely that cytokines triggered hippocampal
p21 expression in acute as well as in the chronic phase of
inflammation. Additional support of this hypothesis comes
from our in vitro experiments. Exposure of WT NPC
with all three pro-inflammatory cytokines resulted in up-
regulation of p21. Induced p21 might be also a result of in-
creased levels of circulating cytokines in DSS-treated mice.
Zonis et al. Journal of Neuroinflammation  (2015) 12:65 Page 10 of 12We reported previously [26] that p21 is expressed ex-
clusively in the SGZ and is co-localized with SOX2, nes-
tin, and DCX. p21 is also induced by acute systemic
inflammation (LPS injection) in neuronal nestin+/SOX2+
and DCX+ progenitors, but not in GFAP+ astroglia [25].
We show here that the total number of p21+ cells was
dramatically increased, and the percentage of SOX2+
and DCX+ cells expressing p21 was also increased
approximately threefold in the hippocampus of DSS-
treated mice. Moreover, the total number of DCX+ cells,
and the number of co-labeled DCX+/Ki-67+ proliferating
cells, was decreased after DSS treatment. It is plausible
that in DSS-treated mice, increase in p21 expression
might be responsible for the decreased early neuronal
progenitor proliferation, evidenced by reduced nestin,
BLBP, and DCX levels. Our previous results showing an
increased rate of hippocampal neurogenesis in p21−/−
mice support this hypothesis [24,25].
p21 induction is associated with increased number of
GFAP-positive cells in vitro, and in vivo, with increased
levels of GFAP in the hippocampus in DSS-treated mice.
However, the increased GFAP expression observed in vivo
likely is attributed to activated astroglia, as the impact of
newly developing astrocytes would be negligible compared
to the total number of astrocyte in this region.
Peripheral inflammation has been suggested as a risk
factor for developing mood, psychotic disorder, and cog-
nitive impairment [72] and can also affect hippocampal
neurogenesis. Acute administration of LPS results in
long-lasting effects on neurogenesis and spatial memory
in rodents, induces depression-like behavior and anxiety,
and suppresses proliferation and survival of new neurons
in the SGZ [72,73]. Moreover, early life inflammatory chal-
lenge (for example, LPS injection) produces long-lasting
anxiety and depression-like behavior and spatial memory
impairment and suppresses neurogenesis [16,74,75]. Our
results suggest that chronic intestinal inflammation can
also negatively impact proliferation and maturation of
neuronal precursors eventually resulting in the reduction
of DG granular cell population and can thereby influence
the properties and functioning of hippocampal circuits.
Given the purported role of hippocampal neurogenesis in
cognitive function and depression, its reduction during
chronic intestinal inflammation might be the cause of be-
havioral changes including cognitive symptoms and mood
disorders that occur in patients with IBD.
Conclusions
Chronic intestinal inflammation suppresses hippocampal
neurogenesis. Increased levels of pro-inflammatory cyto-
kines systemically and in the hippocampus have detrimen-
tal effects on proliferation of progenitors of neuronal
lineage. Cytokine-induced p21 might play an important role
in restraining neuronal progenitor proliferation. Deficienthippocampal neurogenesis may underlie increased rate of
mood disorder and cognitive impairment observed in IBD
patients.
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